← Open Payments lookup

TIFFANY THIBODEAUX: Open Payments

NPI 1265887012 · CARENCRO, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,292 in 49 payments from 11 companies in 2025. Trend: 2023 $230 · 2024 $539 · 2025 $1,292

Food & beverage: $1,292
CompanyPaymentsAmount
Alkermes, Inc.15$459
Otsuka America Pharmaceutical, Inc.4$176
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$150
E.R. Squibb & Sons, L.L.C.3$147
ABBVIE INC.4$141
Supernus Pharmaceuticals, Inc.4$77
Neurocrine BioSciences, Inc.1$68
Takeda Pharmaceuticals U.S.A., Inc.1$22
Collegium Pharmaceutical, Inc.1$19
Lilly USA, LLC1$17

Products named: ARISTADA, LYBALVI, CAPLYTA, COBENFY, VRAYLAR, ABILIFY MAINTENA, Qelbree, REXULTI.

Industry payments across LA — which companies pay providers there.